Evaluation of heart failure patients: objective parameters to assess functional capacity (Q41099214)

26 September 2017

1 reference

title

Evaluation of heart failure patients: objective parameters to assess functional capacity (English)

1 reference

26 September 2017

0 references

Mills RM Jr

1

1 reference

PubMed ID

8790948

26 September 2017

Haught WH

series ordinal

2

1 reference

26 September 2017

1 June 1996

1 reference

26 September 2017

1 reference

26 September 2017

19

1 reference

26 September 2017

6

1 reference

26 September 2017

455-460

1 reference

Active skeletal muscle mass and cardiopulmonary reserve. Failure to attain peak aerobic capacity during maximal bicycle exercise in patients with severe congestive heart failure

26 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

Use of the cardiopulmonary exercise test to evaluate the patient with chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

The maximal stress test: does it have any value in heart failure?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Exercise capacity and quality of life in the treatment of heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Cardiac transplantation as therapy for heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopath

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Predictors of total mortality and sudden death in mild to moderate heart failure. Captopril-Digoxin Study Group

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Characteristics of peak aerobic capacity in symptomatic and asymptomatic subjects with left ventricular dysfunction. The Studies of Left Ventricular Dysfunction (SOLVD) Investigators

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Exercise Testing for Evaluation of Ventricular Function

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Exercise tolerance in patients with heart failure--how should it be measured?

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Comparison of four exercise protocols using anaerobic threshold measurement of functional capacity in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Cardiopulmonary exercise testing in congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Pulmonary artery pressure changes during exercise and daily activities in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Hemodynamic and metabolic basis of impaired exercise tolerance in patients with severe left ventricular dysfunction

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Incremental prognostic value of exercise hemodynamic variables in chronic congestive heart failure secondary to coronary artery disease or to dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Assessing cardiac pumping capability by exercise testing and inotropic stimulation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Decreased coronary sinus oxygen content: A predictor of adverse prognosis in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Assessment of peak oxygen consumption, lactate and ventilatory thresholds and correlation with resting and exercise hemodynamic data in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Ventilatory mechanisms of exercise intolerance in chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Response in oxygen uptake and ventilation during stair climbing in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Predictors of prognosis in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Estimating severity of chronic heart failure: A clinical challenge for the 1990s

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Mitral regurgitation and death while awaiting cardiac transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Influence of mitral regurgitation on the response to captopril therapy for congestive heart failure caused by idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Contribution of skeletal muscle atrophy to exercise intolerance and altered muscle metabolism in heart failure

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960190603

7 January 2021

Identifiers

DOI

10.1002/CLC.4960190603

1 reference

26 September 2017

1 reference

PubMed ID

8790948